Accordingly, it is possible that AMPs have great potential for use in cancer treatments in the future as a chemotherapy drug with a short time frame of interaction (reducing probability of resistance), low toxicity (reducing side effects), high specificity, good solubility, and good tumor penetration [23, 24]. This evidence concerns the gene ADSL and cancer.